Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

INTRODUCTION: Clinical trials of new treatments for rheumatoid arthritis (RA) typically require subjects to have an elevated acute phase reactant (APR), in addition to tender and swollen joints. However, despite the elevation of individual components of the Clinical Disease Activity Index (CDAI) (te...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kay, Jonathan, Morgacheva, Olga, Messing, Susan P, Kremer, Joel M, Greenberg, Jeffrey D, Reed, George W, Gravallese, Ellen M, Furst, Daniel E
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978994/
https://ncbi.nlm.nih.gov/pubmed/24485007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4469
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi